HSP

Hospira Joins the Generic Pharmaceutical Association LAKE FOREST, Ill., July 26 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE:HSP) announced today that its membership has been approved by the Board of Directors of the Generic Pharmaceutical Association (GPhA), an organization "committed to improving lives for less" by representing the industry and its nearly 150 member companies through participation in regulatory, scientific and legislative forums. "We're pleased to become a part of the leading organization representing the generic pharmaceutical industry," said Edward A. Ogunro, Ph.D., senior vice president, Research and Development, Regulatory and Medical Affairs, and chief scientific officer, Hospira. "As the leading provider of generic injectable pharmaceuticals in the United States, we look forward to contributing an active voice to shaping the future of the industry -- helping to increase customer awareness and access to generic pharmaceuticals." Hospira offers the broadest portfolio of generic injectable pharmaceuticals and drug-delivery systems in the United States, with products that address critical therapeutic areas including pain, anesthesia, cardiovascular and infectious disease. Through these high-quality generic alternatives, Hospira is strategically positioned to help reduce the overall cost of healthcare. More than $3 billion of non-biologic branded injectable drug patents are slated to expire in the United States by the end of the decade, and Hospira's pipeline should deliver a steady stream of generic pharmaceuticals to the market. "We are pleased to welcome Hospira to GPhA, and we look forward to their participation in the Association's mission to make American healthcare more affordable," said Kathleen Jaeger, GPhA's president and chief executive officer. "Hospira's products, like those of our other members, have enabled millions of Americans to obtain affordable treatments for critical conditions." About the Generic Pharmaceutical Association (GPhA) GPhA represents the manufacturers and distributors of finished generic pharmaceuticals, manufacturers and distributors of bulk active pharmaceutical chemicals, and suppliers of other goods and services to the generic drug industry. Generics represent 51 percent of the total prescriptions dispensed in the United States, but less than 8 percent of all dollars spent on prescription drugs. The Generic Pharmaceutical Association is committed to improving lives for less. For additional information, visit GPhA's Web site at http://www.gphaonline.org/ . About Hospira Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM) by developing, manufacturing and marketing products that help improve the safety and efficacy of patient care. Created from the core global hospital products business of Abbott Laboratories, Hospira is a new company with 70 years of service to the hospital industry. The company's portfolio includes one of the industry's broadest lines of generic acute-care injectables, integrated solutions for medication management and infusion therapy, and a full-service contract manufacturing business. Headquartered in Lake Forest, Ill., north of Chicago, Hospira has more than 14,000 employees and 15 manufacturing facilities worldwide. Hospira's news releases and other information can be found at http://www.hospira.com/ . DATASOURCE: Hospira, Inc. CONTACT: Media, Stacey Eisen, +1-224-212-2276, or Financial Community, Lynn McHugh, +1-224-212-2363, both of Hospira, Inc. Web site: http://www.hospira.com/ http://www.gphaonline.org/

Copyright